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A Ab bs st tr ra ac ct t    We describe a rare variant of papillary thyroid carcinoma (PTC), the 
Cribriform-Morular Variant (C-MV). A handful of cases have been 
described in the literature of this entity. They exhibit the morphologic 
features of a distinctive papillary neoplasm along with solid, cribriform, 
and squamoid-morular areas. The cribriform and morular features make 
this a separate entity which could be mistaken for a high grade aggressive 
thyroid neoplasm. These lesions are usually associated with familial 
adenomatosis polyposis (FAP) but rarely may be sporadic. We report 
three cases that we have encountered. 
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1.  Report of cases 
Case 1 
Patient was a 32 year old G1P0 white female who presented with an enlarging painless lump in her 
neck for the preceding two years. Ultrasound revealed a large, lobulated, right lobe mass. Serum level 
showed: TSH-0.4 µ IU/ml, T3-1.88ng/ml (N: 0.6-1.81 ng/ml), free T4-1.2 ng/dl (N: 0.8-1.8 ng/dl) and 
24 hour radio active iodine uptake-37%. She underwent a total thyroidectomy and is currently on 
adjuvant radioactive iodine. She also underwent a proctocolectomy for multiple colonic polyps and 
colonic carcinoma. 
Case 2 
Patient was a 14 year old Latin American female with a gradually enlarging right neck mass for 2 
years. CT scan showed several bilateral lesions. Fine needle aspiration showed normal follicular 
cytology. Serum level showed: TSH-1.31 µ IU/ml, T4-0.92ng/ml (N: 0.6-1.81 ng/ml), free T4-2.6 ng/dl 
(N: 0.8-1.8 ng/dl) and 24 hour radio active iodine uptake-28%. She underwent a total thyroidectomy 
with subsequent radioactive ablation. There is no family history of colonic polyposis. 
Case 3 
Patient was a 34 year old asymptomatic HIV positive female with bilateral neck masses. Fine 
needle aspiration of the left lobe lesion showed papillary carcinoma. Serum level showed: TSH-1.92 µ 
IU/ml, free T4-1.1 ng/dl (N: 0.8-1.8 ng/dl) and 24 hour radio active iodine uptake-31%. She underwent 
a total thyroidectomy with subsequent radioactive ablation. She had a colectomy for multiple colonic 
polyps. 
Gross Pathology 
Specimens revealed well-circumscribed, somewhat lobulated tan masses ranging from 1.5-2 cm 
with multiple satellite nodules. There was no lobe predilection. There was no necrosis or hemorrhage 
seen. The remainder of the thyroid was lobulated and beefy. Few lymph nodes were also identified. 
Microscopic Pathology 
The typical nuclear features of PTC could be seen. They were complex branching papillary 
structures lined by cuboidal cells. The nuclei were hyperchromatic, optically clear with longitudinal 
grooves and showed eosinophilic, intranuclear and cytoplasmic inclusions as in classic PTC (Fig 1). 
Some lesions showed an intricate blending of several histological patterns (Fig 2). Cribriform areas had 
back-to-back follicles with anastomozing bars and arches of cells in the absence of intervening 
fibrovascular stroma and accounted for 30-50% of the lesions (Fig 3). The solid areas, which were 
approximately 20-30%, consisted of whorls of cells that form squamoid morules or nests that typically 
do not show any keratinization or intercellular bridges (Fig 4). No colloid or psamomma bodies were 
found in the tumors. Case 3 also showed foci of tall and columnar cell features. 
2.  Comment 
Cribriform-Morular Variant (C-MV) of PTC is a   rare morphologic entity. It was first described 
by Harach et al. [1]
 in association with FAP as a distinctive tumor. A total of 44 cases have been 
documented so far (See Table1). We describe three cases, in two of which the patients have FAP. Case 
2 was lost to follow-up. 
Two cases were women in their 30’s and the third was a 14 year old. The lesions ranged from 1.5 
to 2 cm and were associated with several satellite nodules. There was no lymph node metastasis, 
capsular or vascular invasion. Our cases are similar to that described by Cameselle-Teijeiro et al. [2] 
who first proposed the term and did a study on nine cases. All the cases were seen in women between 
ages of 16-30 years (mean: 21.3). The lesions were predominantly solitary and ranged from 1.5-5.6 cm. 
All except one showed vascular invasion. Two cases also showed lymph node metastasis. In that study, 
immunohistochemical stains were positive for thyroglobulin, epithelial membrane antigen, cytokeratin, 
vimentin, estrogen and progesterone receptors, bcl-2 and Rb proteins. Calcitonin and carcinoembryonic 
antigen were negative. Follow-up showed seven cases with no recurrences. Int. J. Med. Sci. 2004 1(1): 43-49  45 
C-MV of PTC is commonly seen in young females usually less than 30 years of age. The lesions 
are encapsulated or well-circumscribed. While sporadic forms usually appear as an isolated tumors, the 
cases associated with FAP are often multifocal due to different somatic mutations added to the germline 
mutations [3]. They display the characteristic histologic pattern of cribriforming akin that seen in breast 
cancer with morules. Morules appear squamous with no keratinization or cellular bridges. There are 
also follicles showing papillary, trabecular and solid patterns.  
There have been several cases showing germline mutations in the APC gene which have also been 
found in the colonic polyps. Hot spots on codons 1061, 1039 and 698 of the APC gene on exon 15 are 
frequently identified. It has been proposed that β-catenin immunohistochemistry is a feasible screening 
method to identify occult FAP in young patients with thyroid tumors [4]. Recently Xu B [5] suggested 
that accumulation of mutant β-catenin contributes to the development of C-MV of PTC. A handful of 
sporadic cases have also been documented [6]. Table 1 summarizes all the cases in the literature. 
Molecular studies were performed in all our cases and they did not show the hot spots of the APC gene. 
C-MV carries a better prognosis than the other aggressive variants of PTC (tall cell, columnar, 
diffuse sclerosing and diffuse follicular) and poorly differentiated carcinoma. Tall cell variant lacks 
morular, cribriform and spindle cell areas. Columnar cell variant presents in older males. The 
encapsulated form of columnar cell variant is common in females and histologically shows greater 
overlap with C-MV but does not have the morules and cribriform pattern. Hyalinizing trabecular tumor 
shows a zellballen pattern in a hyalinized amyloid-like background. Poorly differentiated (insular) 
carcinoma shows areas mimicking cribriform structures but lacks morules and is associated with a 
higher proliferation index and necrosis. 
This morphologic variant should be borne in mind by pathologists because of its characteristic 
pattern.  The clinician should be alerted to exclude FAP along with appropriate family screening. In 25-
30% of cases, this might provide the first indicator of an underlying FAP syndrome. 
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Tables and Figures 
Table 1 
Cases Sex/A
ge  
(yr) 
FA
P 
Presentation Main  Features  APC 
Mutation 
in thyroid 
Treatment   Outcom
e 
F/19  Yes  Right neck mass  16  separate 
nodules 
ND Total  thyroidectomy  A&W  at 
25 yrs 
F/34 Yes    2  cm  ND 
F/34 Yes    1  focus  ND 
Harach et 
al. [1] 
F/23 Yes    3  cm  ND 
  
F/30  No  Right neck nodule  
at  6 months 
22 mm  Absent  Hemithroidectomy (R), 
Subtotal lobectomy (L), 
Radioactive iodine 
A&W at 
5 yr 
F/16  No  Left neck nodule  
for 1 year 
15 mm  ND  Total thyroidectomy, 
Radioactive iodine 
A&W at 
14 yr 
F/20  No  Left  thyroid  nodule  12 mm (R), 23 
mm (L) 
ND Total  thyroidectomy  A&W  at 
4 yr 
Cameselle-
Teijeiro 
and Chan 
[2] 
F/19  No  Right neck mass  19mm  ND  Total thyroidectomy  Recent 
case 
F/21  No  Anterior neck mass  40 mm  ND  Surgical resection  A&W  at 
1-2 yr 
F/23  No  Anterior neck mass  50 mm, LN met 
+ 
ND Surgical  resection  A&W  at 
1-2 yr 
F/20  No  Anterior neck mass  56 mm  ND  Surgical resection  A&W  at 
1-2 yr 
Yamashita 
et al.[7] 
F/21  No  Anterior neck mass  26 mm  ND  Surgical resection  A&W  at 
1-2 yr 
Mizukami 
et al.[8] 
F/16  No  Left neck nodule  20 mm    Subtotal  thyroidectomy 
and radical neck 
dissection 
A&W at 
5 yr 
Hizawa et 
al.[9] 
F/20  Yes  Right neck mass  18 mm  Exon  15  at 
codon 1061 
Hemithroidectomy (R), 
and LN dissection 
A&W at 
2 yr 
Perrier et 
al.[10] 
11/12 cases 
F/15-
61 yrs 
Yes  Bilateral : 5  18  mm  (0.2-5 
cm) 
multicentric :8 2 
cases with LN 
met’s 
All ND  5 Total thyroidectomy 
5  near total 
thyroidectony 
2 lobectomy 
2 PO Iodine 
10 T4 suppression  
FU:&mo
s-30yr,  
2 
recurred  
1 death 
F/38 Yes  Bilateral  mass  Multifocal  (3-35 
mm) capsular 
and vascular + 
Exon 15 at 
codon 698 
Total thyroidectomy  Recurred 
and died  
F/24 Yes  Bilateral  mass  20-35  mm, 
capsular 
invasion 
Exon 15 at 
codon 698 
Total thyroidectomy  Recurred 
Soravia et 
al.[11] 
F/51  Yes  Bilateral mass  6-23 mm  Exon  9  at 
codon 312 
Total thyroidectomy  NP 
Fenton et 
al.[12] 
F/20 Yes  Diagnosis  made 
retrospectively 
Diagnosis made 
retrospectively 
 
Exon 15 at 
codon 1061 
Total thyroidectomy 
 
A&W at 
14mos 
Cameselle-
Teijeiro et 
al. [6] 
F/27  Yes  Right neck mass x 
14 mos 
21 mm with 
capsular  
and 
angioinvasion 
Exon 15 at 
codon 1309 
 somatic 
mutation 
 
Total thyroidectomy 
 
A&W at 
14mos 
 
F/22 Yes  NP  Encapsulated  Exon  15  at 
codon 1061 
NP NP 
F/20 Yes  NP  8  mm  Exon  15  at 
codon 1309 
NP NP 
Cetta et 
al.[13] 
F/36 Yes  NP  11  mm  Exon  15  at 
codon 1309 
NP NP 
Present 
Cases 
F/32  Yes  Anterior neck  Multifocal  In process  Total thyroidectomy  Recent 
case 
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Fig 1 
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